Can-Fite BioPharma Files Prospectus For Offering ~6.599M Ordinary Shares On Behalf Of Selling Shareholders

Benzinga Newsdesk www.benzinga.com Neutral 93.1%

Neg 0% Neu 93.1% Pos 0%

https://www.sec.gov/Archives/edgar/data/1536196/000121390026103584/ea0306467-f3_canfite.htm

Comments

No comments yet. Be the first!